Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment
Open Access
- 1 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 59 (3) , 974-985
Abstract
Leukocyte cell-derived chemotoxin 2 (LECT2) has been shown to act as a tumor suppressor in hepatocellular carcinoma (HCC). However, the underlying mechanism has not yet been completely defined. Here, we employ a LECT2-affinity column plus liquid chromatography coupled with tandem mass spectrometry to identify LECT2-binding proteins and found that MET receptor strongly interacted with LECT2 protein. Despite the presence of hepatocyte growth factor, the LECT2 binding causes an antagonistic effect to MET receptor activation through recruitment of protein tyrosine phosphatase 1B. The antagonistic effect of LECT2 on MET activation also mainly contributes to the blockage of vascular invasion and metastasis of HCC. Furthermore, serial deletions and mutations of LECT2 showed that the HxGxD motif is primarily responsible for MET receptor binding and its antagonistic effects. Conclusion: These findings reveal a novel, specific inhibitory function of LECT2 in HCC by the direct binding and inactivation of MET, opening a potential avenue for treating MET-related liver cancer. (HEPATOLOGY 2014;59:974-985)Keywords
This publication has 28 references indexed in Scilit:
- Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in miceJournal of Clinical Investigation, 2012
- Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular CarcinomaAnti-Cancer Agents in Medicinal Chemistry, 2011
- The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic targetCancer Gene Therapy, 2011
- N-α-Acetyltransferase 10 Protein Suppresses Cancer Cell Metastasis by Binding PIX Proteins and Inhibiting Cdc42/Rac1 ActivityCancer Cell, 2011
- Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomasOncogene, 2006
- Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of β-catenin in the liverHepatology, 2004
- Receptor Tyrosine Kinases as Target for Anti-Cancer TherapyCurrent Pharmaceutical Design, 2002
- Molecular cloning of human and bovine LECT2 having a neutrophil chemotactic activity and its specific expression in the liverBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- A Novel Growth-Promoting Factor Derived from Fetal Bovine Cartilage, Chondromodulin IIJournal of Biological Chemistry, 1996
- Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2Immunology Letters, 1996